← Back to practice questions

BiochemStep Practice Question

PCSK9 inhibitor mechanism (alirocumab) Clinical Behavior Pharmacology Practice Question

Lipid Metabolism | Lipid Metabolism | clinical behavior / pharmacology

What this page covers

Practice Step 1-style biochemistry questions on PCSK9 inhibitor mechanism (alirocumab), including Heterozygous FH, max statin, ezetimibe, LDL still above target, alirocumab added, effect on LDL receptors, with emphasis on clinical behavior / pharmacology and answer-choice reasoning.

How to use this page

Review the topic and reasoning focus, then practice Step 1-style questions inside BiochemStep. The question set emphasizes mechanism-first answer-choice reasoning rather than passive content review.